Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 12:11 pm Purchase | 2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,581,642 9.500% | 101,358![]() (+2.26%) | Filing History |
2025-02-14 12:09 pm Purchase | 2024-12-31 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 17,122,563 11.000% | 17,122,563![]() (New Position) | Filing History |
2025-02-14 12:06 pm Sale | 2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 2,606,938 5.430% | -838,425![]() (-24.33%) | Filing History |
2025-02-14 12:01 pm Purchase | 2024-12-31 | 13G | Inozyme Pharma, Inc. INZY | Eventide Asset Management, LLC | 2,220,000 3.460% | 2,220,000![]() (New Position) | Filing History |
2024-11-14 4:37 pm Sale | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 3,075,907 6.400% | -1,294,117![]() (-29.61%) | Filing History |
2024-11-14 12:55 pm Sale | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,480,284 9.400% | -508,463![]() (-10.19%) | Filing History |
2024-11-14 12:25 pm Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 3,445,363 7.220% | 751,782![]() (+27.91%) | Filing History |
2024-11-12 11:44 am Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 3,406,072 7.100% | 37,915![]() (+1.13%) | Filing History |
2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 3,368,157 7.100% | 835,515![]() (+32.99%) | Filing History |
2024-07-10 1:12 pm Purchase | 2024-06-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,988,747 10.600% | 4,988,747![]() (New Position) | Filing History |
2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 2,693,581 5.780% | 636,581![]() (+30.95%) | Filing History |
2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Mirum Pharmaceuticals, Inc. MIRM | VANGUARD GROUP INC | 2,476,244 5.310% | 2,476,244![]() (New Position) | Filing History |
2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 2,532,642 5.400% | 854,735![]() (+50.94%) | Filing History |
2023-12-29 4:01 pm Sale | 2023-12-21 | 13D | Mirum Pharmaceuticals, Inc. MIRM | New Enterprise Associates 16, L.P. | 0 0.000% | -2,186,243![]() (Position Closed) | Filing History |
2023-09-18 4:35 pm Purchase | 2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% | 4,370,024![]() (New Position) | Filing History |
2023-09-05 3:11 pm Purchase | 2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX L.P. | 6,226,392 13.400% | 1,815,285![]() (+41.15%) | Filing History |
2023-06-23 2:32 pm Sale | 2023-06-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM | New Enterprise Associates 16, L.P. | 2,186,243 5.800% | -2,000,000![]() (-47.78%) | Filing History |
2023-05-03 4:58 pm Sale | 2023-05-03 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Deerfield Mgmt, L.P. | 0 0.000% | -2,032,335![]() (Position Closed) | Filing History |
2023-04-14 12:45 pm Purchase | 2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX L.P. | 4,411,107 11.600% | 549,326![]() (+14.22%) | Filing History |
2023-03-08 2:15 pm Sale | 2023-02-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 1,677,907 4.600% | -458,770![]() (-21.47%) | Filing History |